- Dabigatran2010 | Faculty of Medicine in Hradec Králové
- Dabigatran. New clinical experience2010 | Faculty of Medicine in Hradec Králové
- Dabigatrane2008 | First Faculty of Medicine
- Risks of treatment by dabigatran in seniors with chronic kidney disease2020 | Publication without faculty affiliation
- The first experience with dabigatran antidote in the University Hospital Pilsen2016 | Faculty of Medicine in Pilsen
- Dabigatran - clinical evidence for treatment in patients with thromboembolism2016 | First Faculty of Medicine
- Dabigatran in the treatment of recurrent deep vein thrombosis and pulmonary embolism2015 | Faculty of Medicine in Hradec Králové
- Dabigatran-etexilate (Pradaxa®) in prevention of strokes in patients with atrial fibrillation2012 | Publication without faculty affiliation
- Anticoagulation with dabigatran and the new recommendations of the European Society of Cardiology for the management of atrial fibrillation2012 | Publication without faculty affiliation
- Dabigatran pharmacogenetics and secondary prevention of ischemic stroke2022 | Second Faculty of Medicine
- Dabigatran etexilate - a breakthrough in antithrombotic therapy in cardiology?2011 | Publication without faculty affiliation
- Dabigatran in the prevention of stroke in patients with atrial fibrilation2011 | First Faculty of Medicine, Third Faculty of Medicine
- Dabigatran etexilate - a new promising antithrombotic agent2010 | First Faculty of Medicine, Third Faculty of Medicine
- Spontaneous rebound of the anticoagulant effect of accumulated dabigatran after the antagonist activity cessation: Case report of life-threatening haemorrhage2018 | Third Faculty of Medicine
- Guidelines of Czech Association for Thrombosis and Haemostasis of the Czech Medical Association of J. E. Purkyně for safety treatment with new oral anticoagulants (NOAC) - dabigatran etexilate, apixaban and rivaroxaban2015 | First Faculty of Medicine
- Long-term experience with dabigatran anticoagulation therapy in atrial fibrilation. RELY-ABLE study2013 | Publication without faculty affiliation
- Efficacy and safety profile of dabigatran in the prevention of venous thromboembolism in patients with moderate renal insufficiency after total knee or hip replacement surgery in patients over 75 years2009 | First Faculty of Medicine
- RE-DUAL PCI trial - percutaneous coronary intervention in patient with atrial fibrillation treated with dabigatran2018 | Publication without faculty affiliation
- Laboratory monitoring of new direct anticoagulants2014 | First Faculty of Medicine
- Anticoagulation with new antithrombotic agents - recommendations for daily practice2013 | Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 1160.113Publication without faculty affiliation
- Extended use of dabigatran, warfarin, or placebo in venous thromboembolism2013 | Faculty of Medicine in Hradec Králové
- Repeated Administration of Idarucizumab to a Patient with Dabigatran Overdose2018 | Faculty of Medicine in Pilsen
- Wasn't there any other way? First experiences with idarucizumab in Pilsen - case reports2017 | Publication without faculty affiliation
- New direct oral anticoagulants2016 | Publication without faculty affiliation
- Anticoagulation therapy 20162016 | Second Faculty of Medicine
- New direct oral anticoagulants (NOAC) - solutions to potential problems with coagulation assessment2014 | First Faculty of Medicine
- Clinical use of the new antithrombotics2010 | Faculty of Medicine in Hradec Králové
- Treatment of emergencies associated with bleeding risk in patients taking new oral anticoagulants - options concerning termination of their effect2016 | First Faculty of Medicine, Third Faculty of Medicine
- Monitoring of the efficacy of novel oral anticoagulants2014 | Second Faculty of Medicine